Alto Neuroscience (ANRO) Other Non-Current Assets (2024 - 2026)
Alto Neuroscience (ANRO) reported Other Non-Current Assets of $500000.0 for Q1 2026, down 12.13% on a YoY basis from $569000.0 in Q1 2025, and up 47.93% sequentially from $338000.0 in Q4 2025.
Alto Neuroscience (ANRO) Other Non-Current Assets (2024 - 2026) Analysis & Trends
Alto Neuroscience (ANRO) has 3 years of Other Non-Current Assets data on file, last reported at $500000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 12.13% year-over-year to $500000.0; the trailing twelve-month figure through Mar 2026 stood at $500000.0 (down 12.13% YoY), and the FY2025 full-year result was $338000.0, up 8350.0% from the prior year.
- Other Non-Current Assets climbed to $500000.0 in Q1 2026, from $338000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $570000.0 in Q3 2025 to a low of $4000.0 in Q2 2024.
- A 3-year average of $338111.1 and a median of $500000.0 in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets surged 12400.0% in 2025 and decreased 12.13% in 2026, its largest moves.
- Tracing ANRO's Other Non-Current Assets over 3 years: stood at $4000.0 in 2024, then surged by 8350.0% to $338000.0 in 2025, then soared by 47.93% to $500000.0 in 2026.
- Business Quant data shows ANRO's Other Non-Current Assets at $500000.0 in Q1 2026, $338000.0 in Q4 2025, and $570000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Alto Neuroscience | 881.86 Mn | 881.86 Mn | - | 500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 338,000.00 |
| Sep 30, 2025 | 570,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 569,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | 58,000.00 |